Intuitive Surgical, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- David J. Rosa
- Full Time Employees
- 17,021
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 1020 Kifer Road Sunnyvale CA United States of America 94086-5304
- IPO Date
- Jun 16, 2000
- CIK
- 0001035267
- Website
- intuitive.com
- Similar Companies
- Business
- Intuitive Surgical, Inc. develops, manufactures, and markets advanced robotic-assisted surgical systems designed to enhance the quality and access to minimally invasive care globally. Its core products include the da Vinci Surgical System, which enables surgeons to perform a wide range of complex surgical procedures across specialties such as general surgery, urology, gynecology, cardiothoracic, and head and neck surgery using minimally invasive techniques. The company also offers the Ion Endoluminal System, a robotic platform for diagnostic endoluminal procedures enabling minimally invasive lung biopsies through advanced imaging and navigation technology. Intuitive’s product suite includes stapling, energy, and core instrumentation compatible with its multi-port da Vinci systems, alongside progressive learning pathways that facilitate clinical adoption, and a comprehensive infrastructure of service and support including installation, maintenance, technical support, proactive system health monitoring, and integrated digital capabilities that provide hospitals with data-driven insights to optimize surgical performance. Founded in 1995 and headquartered in Sunnyvale, California, Intuitive Surgical operates globally, supporting hospitals and surgical teams across over 60 countries. In the last 1-2 years, the company has advanced the commercial launch of its da Vinci 5 Surgical System, receiving regulatory clearances from the US FDA and CE mark in 2024, with 2025 focused on scaling the adoption of this platform through enhanced hardware and software upgrades featuring increased computing power and digital capabilities. Intuitive reported significant growth in system placements and procedure volumes, with a 14% year-over-year increase in installed base and 17% procedural growth as of mid-2025. Strategic priorities include expanding its robotic surgery ecosystem, reinforcing its recurring revenue model—which accounted for 84% of revenue in 2024—and furthering its Quintuple Aim framework aimed at improving patient outcomes, care team experience, access to care, and lowering total costs. Additionally, leadership transitioned in mid-2025 with President Dave Rosa promoted to CEO, signaling a new phase of growth and innovation focus. Despite rising competition in the robotic surgery field, Intuitive remains a dominant market leader through continuous technological innovation and strategic expansion. This comprehensive offering positions Intuitive Surgical as a pioneer and global leader in robotic-assisted, minimally invasive surgical technology, serving healthcare providers with products, services, and digital innovations that collectively enhance surgical precision, patient recovery, and overall healthcare system efficiency.
Intuitive Surgical, Inc. $ISRG Shares Bought by Bank of Nova Scotia
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now?
Why Intuitive Surgical, Inc. (ISRG) is a Top Growth Stock for the Long-Term
Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
Bet on 5 Top-Ranked Stocks With Rising P/E
Intuitive Shares Vision for an AI-Enabled Future of Healthcare
Is ISRG Stock Worth Buying as Growth Stays Strong but Risks Rise
ISRG Trends Point to AI, Lung Biopsy Growth and Margin Pressure
ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue
Can ISRG Maintain Its Premium Valuation Amid Slower Procedure Growth?
Is Intuitive Surgical a Buy After Its Latest Earnings Report?
Intuitive Surgical Stock Is Trading at Multi-Year Lows: Is It a Bargain Buy?
Intuitive Surgical, Inc. $ISRG Shares Purchased by Andra AP fonden
AlTi Global Inc. Purchases 2,356 Shares of Intuitive Surgical, Inc. $ISRG
3 Reasons Growth Investors Will Love Intuitive Surgical (ISRG)
Down 15% in 4 Weeks, Here's Why You Should You Buy the Dip in Intuitive Surgical (ISRG)
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Intuitive Surgical: The Correction Has Done The Work The Fundamentals Could Not
Why Intuitive Surgical Stock Dropped This Week